Published online before print September 7, 2006

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0606409v1 81/1/144    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ralainirina, N. Articles by Zimmer, J. Search for Related Content PubMed PubMed Citation Articles by Ralainirina, N. Articles by Zimmer, J.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0606409

Received for publication June 22, 2006.
Revised August 2, 2006.
Accepted for publication August 3, 2006.

Article

Control of natural killer (NK) cell functions by CD4⁺CD25⁺ regulatory T cells

Natacha Ralainirina ^*, Aurélie Poli ^*, Tatiana Michel ^*, Linda Poos ^*, Emmanuel Andrès , François Hentges ^*, and Jacques Zimmer ^*@

*Laboratoire d’Immunogénétique-Allergologie, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg-City, France; and Service de Médecine Interne, Clinique Médicale B, Hôpitaux Universitaires de Strasbourg, France

^@ To whom correspondence should be addressed. E-mail: jacques.zimmer{at}crp-sante.lu.

Abstract

Regulatory T cells (Treg) are key players in the maintenance of peripheral tolerance. As a result of suppressive effects on CD4⁺ and CD8⁺ effector T cells, Treg control the adaptive immune system and prevent autoimmunity. In addition, they inhibit B lymphocytes, dendritic cells, and monocytes/macrophages. It is interesting that several recent papers show that CD4⁺CD25⁺ Treg are also able to inhibit NK cells. Thus, Treg exert their control on immune responses from the onset (triggering of innate immune cells) to the effector phase of adaptive immunity (B and T cell-mediated responses). That Treg inhibit NK cells suggests that their uncontrolled activation might break self-tolerance and induce "innate" autoimmune pathology. Conversely, Treg-mediated suppression of NK cell functions might have negative effects, as these cells are important in defense against infections and cancer. It is conceivable that Treg might dampen efficient activation of NK cells in these diseases.

Key Words: suppression • inhibition • TGF- • NKG2D

This article has been cited by other articles:

				H. Brauner, M. Elemans, S. Lemos, C. Broberger, D. Holmberg, M. Flodstrom-Tullberg, K. Karre, and P. Hoglund Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice J. Immunol., March 1, 2010; 184(5): 2272 - 2280. [Abstract] [Full Text] [PDF]

				T. Ishii, T. Ishida, A. Utsunomiya, A. Inagaki, H. Yano, H. Komatsu, S. Iida, K. Imada, T. Uchiyama, S. Akinaga, et al. Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma Clin. Cancer Res., March 1, 2010; 16(5): 1520 - 1531. [Abstract] [Full Text] [PDF]

				G. Schlecht-Louf, M. Renard, M. Mangeney, C. Letzelter, A. Richaud, B. Ducos, I. Bouallaga, and T. Heidmann Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses PNAS, February 23, 2010; 107(8): 3782 - 3787. [Abstract] [Full Text] [PDF]

				W. Y. Kim, Y. K. Jeon, T. M. Kim, J. E. Kim, Y. A. Kim, S.-H. Lee, D.-W. Kim, D. S. Heo, and C.-W. Kim Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma Ann. Onc., October 1, 2009; 20(10): 1688 - 1696. [Abstract] [Full Text] [PDF]

				G. R. Kinsey, R. Sharma, L. Huang, L. Li, A. L. Vergis, H. Ye, S.-T. Ju, and M. D. Okusa Regulatory T Cells Suppress Innate Immunity in Kidney Ischemia-Reperfusion Injury J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1744 - 1753. [Abstract] [Full Text] [PDF]

				T. J. Ruckwardt, K. L. Bonaparte, M. C. Nason, and B. S. Graham Regulatory T Cells Promote Early Influx of CD8+ T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance Disparities J. Virol., April 1, 2009; 83(7): 3019 - 3028. [Abstract] [Full Text] [PDF]

				O. Sobolev, P. Stern, A. Lacy-Hulbert, and R. O. Hynes Natural Killer Cells Require Selectins for Suppression of Subcutaneous Tumors Cancer Res., March 15, 2009; 69(6): 2531 - 2539. [Abstract] [Full Text] [PDF]

				G. Gong, L. Shao, Y. Wang, C. Y. Chen, D. Huang, S. Yao, X. Zhan, H. Sicard, R. Wang, and Z. W. Chen Phosphoantigen-activated V{gamma}2V{delta}2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection Blood, January 22, 2009; 113(4): 837 - 845. [Abstract] [Full Text] [PDF]

				H. Yano, T. Ishida, A. Inagaki, T. Ishii, J. Ding, S. Kusumoto, H. Komatsu, S. Iida, H. Inagaki, and R. Ueda Defucosylated Anti CC Chemokine Receptor 4 Monoclonal Antibody Combined with Immunomodulatory Cytokines: A Novel Immunotherapy for Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome Clin. Cancer Res., November 1, 2007; 13(21): 6494 - 6500. [Abstract] [Full Text] [PDF]

				J. N. Beilke and R. G. Gill Frontiers in Nephrology: The Varied Faces of Natural Killer Cells in Transplantation Contributions to Both Allograft Immunity and Tolerance J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2262 - 2267. [Abstract] [Full Text] [PDF]